Mutated DNA Restored to Normal in Gene Therapy Advance
The small study in patients with a rare disorder that causes liver and lung damage showed the potential for precisely ...
Hosted on MSN25d
Baptist, tech company share lung cancer awareness
Mississippi Baptist Medical Center teamed up with Genentech to bring awareness of healthy lungs for Lung Cancer Awareness Month. An exhibit of inflatable lungs was set up Wednesday in the hospital ...
BioSpace8d
Roche Continues Regulatory Run With Acute Stroke Expansion for Heart Attack Drug
According to Roche subsidiary Genentech, which announced the label expansion on Monday, TNKase is the first new drug for ...
Yahoo Finance8d
Genentech wins FDA approval for second stroke treatment
Genentech has secured a second marketed stroke therapy after the US Food and Drug Administration (FDA) approved a label expansion for clot-dissolving agent TNKase (tenecteplase) – the first ...
Wall Street Journal1mon
Pharma Companies Turn to AI to Speed Up Drug Development, But Hit Hurdles
When Genentech licensed experimental drug vixarelimab from Kiniksa Pharmaceuticals KNSA3.31%increase; green up pointing triangle, its scientists thought they had a future lung medicine in their hands.
Nasdaq10d
Genentech: Phase III Study Shows Xolair More Effective, Fewer Side Effects For Food Allergies
(RTTNews) - Genentech, a member of the Roche Group (RHHBY), announced new positive data from Stage 2 and Stage 3 of the National Institutes of Health (NIH)-sponsored Phase III OUtMATCH study ...